For instance, the CHARGE consortium investigated 30 candidate genes that code for proteins that are direct targets of antihypertensive drugs and found that only a few (ADRB1, AGT, ACE) had significant, modest associations with blood pressure levels (< 1mm Hg) or with hypertension (<10% difference in risk) [28]. This evidence concerns the gene ACE and Hypertension.